• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Thomas H. Lee Partners Appoints Paul Black As a Consultant for Healthcare Group

    10/11/22 9:00:00 AM ET
    $CERN
    $HQY
    $MDRX
    Managed Health Care
    Health Care
    Real Estate
    Real Estate
    Get the next $CERN alert in real time by email

    Healthcare IT Industry Expert Will Support the Firm's HCIT Strategy

    Thomas H. Lee Partners, L.P. ("THL"), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firm's healthcare investment group. Black, who brings more than 25 years of experience leading companies in healthcare information technology ("Healthcare IT"), will support the team's efforts in identifying, sourcing, and growing investment opportunities across the healthcare market.

    "We are very pleased to welcome Paul to THL as a consultant for the firm's healthcare group," said Shahab Vagefi, Managing Director at THL. "THL has had a longstanding focus in healthcare and technology. As we continue finding investment opportunities at the intersection of these industries, Paul's significant experience creating and executing a strategic vision for businesses in Healthcare IT will be greatly beneficial as we add more high-quality companies seeking to improve the healthcare ecosystem to our portfolio."

    In this role, Black will support the healthcare group in deal sourcing, due diligence for potential investments, and developing new relationships with founders and management teams across the healthcare landscape. He will also serve as an advisor to portfolio companies to support their growth.

    "THL's thesis-driven approach and dedicated focus on Healthcare IT has enabled it to work with unique companies across the healthcare landscape," said Paul Black. "I am pleased to join such an exceptional team and look forward to advancing the firm's strategy."

    Prior to joining THL, Black served 10 years as a Director and CEO of Allscripts, (NASDAQ:MDRX) a global leader in healthcare information technology solutions. Before that, he was the COO of Cerner Corporation (NASDAQ:CERN) for more than a decade. Black is currently a director of HealthEquity (NASDAQ:HQY), Community CareLink, The Advancement Board University of Kansas Health System and The Harry S. Truman Presidential Library & Museum.

    About Thomas H. Lee Partners, L.P.

    Thomas H. Lee Partners, L.P. ("THL") is a premier private equity firm investing in middle-market growth companies exclusively within three sectors: Healthcare, Financial Technology & Services, and Technology & Business Solutions. THL couples deep sector expertise through an Identified Sector Opportunity ("ISO") process with dedicated internal operating resources from its Strategic Resource Group ("SRG") to transform and build great companies of lasting value in partnership with management. The Firm's domain expertise and resources help to build great companies with an aim to accelerate growth, improve operations and drive long-term sustainable value. THL has been an active investor in Healthcare and Healthcare IT for decades with investments in Intelligent Medical Objects, Nextech, Qventus, Intermedix, SeniorLink and numerous other Healthcare and Technology companies. Since 1974, THL has raised more than $34 billion of equity capital, invested in over 160 companies and completed more than 500 add-on acquisitions representing an aggregate enterprise value at acquisition of over $210 billion.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20221011005107/en/

    Get the next $CERN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CERN
    $HQY
    $MDRX

    CompanyDatePrice TargetRatingAnalyst
    HealthEquity Inc.
    $HQY
    11/13/2025$100.00Market Perform
    BMO Capital Markets
    HealthEquity Inc.
    $HQY
    5/22/2025$105.00 → $112.00Outperform
    RBC Capital Mkts
    HealthEquity Inc.
    $HQY
    3/25/2025$120.00 → $115.00Outperform → Strong Buy
    Raymond James
    HealthEquity Inc.
    $HQY
    12/4/2024$126.00Outperform
    Mizuho
    HealthEquity Inc.
    $HQY
    11/15/2024$108.00Neutral
    Goldman
    HealthEquity Inc.
    $HQY
    4/4/2024$101.00Mkt Outperform
    JMP Securities
    HealthEquity Inc.
    $HQY
    4/2/2024$86.00 → $108.00Overweight
    JP Morgan
    Veradigm Inc.
    $MDRX
    3/19/2024$15.00 → $10.00Buy → Hold
    Deutsche Bank
    More analyst ratings

    $CERN
    $HQY
    $MDRX
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by HealthEquity Inc.

    SCHEDULE 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)

    11/5/25 11:35:23 AM ET
    $HQY
    Real Estate

    SEC Form 144 filed by HealthEquity Inc.

    144 - HEALTHEQUITY, INC. (0001428336) (Subject)

    10/8/25 4:15:51 PM ET
    $HQY
    Real Estate

    SEC Form 144 filed by HealthEquity Inc.

    144 - HEALTHEQUITY, INC. (0001428336) (Subject)

    9/5/25 4:08:20 PM ET
    $HQY
    Real Estate

    $CERN
    $HQY
    $MDRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $CERN
    $HQY
    $MDRX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    HealthEquity to Enhance Member Experience with Agentic AI

    DRAPER, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY), the nation's largest Health Savings Account (HSA) and consumer-directed benefits administrator, today announced a new development in building upon its technology investments to transform member experience. The company will deploy agentic AI capabilities that fundamentally change how members access support, working with leading customer experience (CX) agent builder Parloa to mark a significant evolution in leveraging intelligent, conversational AI that understands member needs and takes action in real time. "Healthcare is personal. Money is personal. At HealthEquity, we exist at the intersection of both," sai

    11/13/25 9:00:00 AM ET
    $HQY
    Real Estate

    Veradigm Adds Sentara Health Plans to Veradigm Payer Insights Solution

    Major Mid-Atlantic and Southeast US Health Plan to Deploy Integrated Care Gap Alerting in Early 2026 Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, announced today a new agreement with Sentara Health Plans, a prominent regional health plan, serving more than one million members. Sentara will implement the Veradigm Payer Insights software solution to deliver patient-specific care gap alerts within the electronic health record (EHR) systems used by its network providers. Veradigm Payer Insights displays critical care gap alerts directly into the provider's existing EHR workflow. This seamless integration empowers healthcare payers to support their pr

    11/10/25 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    HealthEquity Announces Third Quarter Earnings Date

    DRAPER, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest Health Savings Accounts ("HSA") and consumer-directed benefits administrator, today announced plans to release financial results of its third quarter of fiscal 2026 following the close of regular stock market trading hours on Wednesday, December 3, 2025. Following the news release, HealthEquity management plans to host a conference call for investors on Wednesday, December 3, 2025, at 4:30 p.m. Eastern Time during which management will review the Company's financial results. HealthEquity Third Quarter Fiscal Year 2026 Results Conference CallDate: December

    11/5/25 4:01:00 PM ET
    $HQY
    Real Estate

    Stonehill Capital Management Llc bought $66,001,500 worth of shares (10,222,875 units at $6.46) (SEC Form 4) (Amendment)

    4/A - Veradigm Inc. (0001124804) (Issuer)

    3/15/24 5:16:45 PM ET
    $MDRX
    EDP Services
    Technology

    Stonehill Capital Management Llc bought $66,001,500 worth of shares (10,222,875 units at $6.46) (SEC Form 4)

    4 - Veradigm Inc. (0001124804) (Issuer)

    3/4/24 9:50:46 PM ET
    $MDRX
    EDP Services
    Technology

    $CERN
    $HQY
    $MDRX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on HealthEquity with a new price target

    BMO Capital Markets initiated coverage of HealthEquity with a rating of Market Perform and set a new price target of $100.00

    11/13/25 9:13:59 AM ET
    $HQY
    Real Estate

    RBC Capital Mkts resumed coverage on HealthEquity with a new price target

    RBC Capital Mkts resumed coverage of HealthEquity with a rating of Outperform and set a new price target of $112.00 from $105.00 previously

    5/22/25 9:53:52 AM ET
    $HQY
    Real Estate

    HealthEquity upgraded by Raymond James with a new price target

    Raymond James upgraded HealthEquity from Outperform to Strong Buy and set a new price target of $115.00 from $120.00 previously

    3/25/25 8:22:31 AM ET
    $HQY
    Real Estate

    $CERN
    $HQY
    $MDRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, General Counsel Ladd Delano sold $138,105 worth of shares (1,500 units at $92.07), decreasing direct ownership by 2% to 76,979 units (SEC Form 4)

    4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    10/22/25 3:47:15 PM ET
    $HQY
    Real Estate

    EVP, General Counsel Ladd Delano covered exercise/tax liability with 977 shares, decreasing direct ownership by 1% to 78,479 units (SEC Form 4)

    4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    10/8/25 8:59:42 PM ET
    $HQY
    Real Estate

    EVP & CFO Lucania James M covered exercise/tax liability with 2,393 shares, decreasing direct ownership by 3% to 87,036 units (SEC Form 4)

    4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    10/8/25 5:18:35 PM ET
    $HQY
    Real Estate

    $CERN
    $HQY
    $MDRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Veradigm Inc.

    SC 13G - Veradigm Inc. (0001124804) (Subject)

    11/14/24 4:05:58 PM ET
    $MDRX
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Veradigm Inc.

    SC 13G/A - Veradigm Inc. (0001124804) (Subject)

    11/14/24 1:11:13 PM ET
    $MDRX
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Veradigm Inc.

    SC 13G/A - Veradigm Inc. (0001124804) (Subject)

    11/8/24 10:29:29 AM ET
    $MDRX
    EDP Services
    Technology

    $CERN
    $HQY
    $MDRX
    Leadership Updates

    Live Leadership Updates

    View All

    Veradigm Appoints Tehsin Syed as Chief Product and Technology Officer

    Healthcare IT Veteran - former AWS and Cerner senior executive - to lead and accelerate innovation across Veradigm's unique footprint Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, today appoints Tehsin Syed, a healthcare technology leader with over two decades of experience, as Chief Product and Technology Officer. Syed most recently served as General Manager, AWS Health AI (Amazon Web Services). Under his leadership, the organization scaled as a growth engine, with net-new products for ambient clinical documentation, genomics, and medical imaging, and interoperability elevated to enterprise grade - capabilities trusted by providers, payers, bioph

    11/3/25 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology

    HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation

    DRAPER, Utah, Sept. 25, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation's largest Health Savings Accounts (HSAs) and consumer-directed benefits administrator, today announced the appointment of new senior executives to accelerate the company's strategic vision and capitalize on expanding market opportunities. Mukund Ramachandran joins as Chief Marketing Officer and Garett Kitch as Senior Vice President of Client Sales & Relationship Management, effective September 29, 2025. The appointments come as HealthEquity continues to execute against record financial performance, alongside the largest HSA eligibility expansion in 20 years following recent federal legislation.

    9/25/25 9:00:00 AM ET
    $HQY
    Real Estate

    Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors

    Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors NEW YORK, Sept. 25, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ: PAVM), today announced the appointment of accomplished healthcare executive John R. Palumbo to its Board of Directors, effective September 22, 2025. "John is a highly accomplished executive whose 40 years of healthcare leadership experience spans earl

    9/25/25 8:01:00 AM ET
    $LUCD
    $MDRX
    $PAVM
    Medical/Dental Instruments
    Health Care
    EDP Services
    Technology

    $CERN
    $HQY
    $MDRX
    Financials

    Live finance-specific insights

    View All

    HealthEquity Announces Third Quarter Earnings Date

    DRAPER, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest Health Savings Accounts ("HSA") and consumer-directed benefits administrator, today announced plans to release financial results of its third quarter of fiscal 2026 following the close of regular stock market trading hours on Wednesday, December 3, 2025. Following the news release, HealthEquity management plans to host a conference call for investors on Wednesday, December 3, 2025, at 4:30 p.m. Eastern Time during which management will review the Company's financial results. HealthEquity Third Quarter Fiscal Year 2026 Results Conference CallDate: December

    11/5/25 4:01:00 PM ET
    $HQY
    Real Estate

    HealthEquity Reports Second Quarter Ended July 31, 2025 Financial Results

    Highlights of the second quarter include: Revenue of $325.8 million, an increase of 9% compared to $299.9 million in Q2 FY25.Net income of $59.9 million, an increase of 67% compared to $35.8 million in Q2 FY25, with non-GAAP net income of $94.6 million, an increase of 24% compared to $76.3 million in Q2 FY25.Net income per diluted share of $0.68, an increase of 70% compared to $0.40 in Q2 FY25, with non-GAAP net income per diluted share of $1.08, an increase of 26% compared to $0.86 in Q2 FY25.Adjusted EBITDA of $151.1 million, an increase of 18% compared to $128.3 million in Q2 FY25.10.0 million HSAs, an increase of 6% compared to Q2 FY25.Total HSA Assets of $33.1 billion, an increase of

    9/2/25 4:01:00 PM ET
    $HQY
    Real Estate

    Veradigm Amends and Extends Stockholder Rights Plan

    Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the "Board") has approved an amendment to extend the Company's existing Stockholder Rights Plan for an additional six months (the "Rights Plan"). The Rights Plan, adopted on February 26, 2024, was due to expire at 5:00PM New York City time on August 20, 2025. Under the terms of the amendment to the Rights Plan, the scheduled expiration date of the Rights Plan has been extended to February 20, 2026. In addition, the amendment to the Rights Plan changes the triggering threshold such that the rights would become exercisable only if a person or group acquires bene

    8/20/25 4:01:00 PM ET
    $MDRX
    EDP Services
    Technology